40. Takayasu arteritis Clinical trials / Disease details

Clinical trials : 25 / Drugs : 50 - (DrugBank : 21) / Drug target genes : 25 - Drug target pathways : 114

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04161898 (ClinicalTrials.gov)	February 4, 2020	12/11/2019	A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy ...	Takayasu Arteritis (TAK)	Drug: Upadacitinib;Drug: Placebo for Upadacitinib;Drug: Prednisolone	AbbVie	NULL	Recruiting	18 Years	N/A	All	54	Phase 3	Japan;Korea, Republic of;Turkey

First Previous1Next Last